T-COVRIX
Live / Applied — Extension of time to oppose received (as of 11 Aug 2026)
What this means for you
Not registered yet, but its 25 Nov 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99515352
- Mark type
- Word mark
- Filed
- 25 Nov 2025
- Published for opposition
- 21 Jul 2026
- Attorney of record
- Alicia M. Passerin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of infectious diseases; Medicinal preparations for the treatment and prevention of cancer and infectious diseases in the nature of coronavirus for administration as a vaccine; Pharmaceutical preparations for the prevention of infectious diseases in the nature of coronavirus for administration as a vaccine; Pharmaceutical preparations for the treatment of cancer and coronavirus for administration as a vaccine; Pharmaceutical preparations for the prevention of cancer and coronavirus for administration as a vaccine; Biological preparations for the prevention and treatment of cancer and infectious diseases in the nature of coronavirus for administration as a vaccine
Owner
- ImmunityBio, Inc., San Diego, CA, US
- ImmunityBio, Inc., San Diego, CA, US
Board proceedings on this mark
- Extension of Time to Oppose No. 99515352 — GlaxoSmithKline Biologicals SA v. ImmunityBio, Inc., filed 11 Aug 2026 (Open)
Prosecution history
- 11 Aug 2026 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 21 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Jul 2026 — PUBLISHED FOR OPPOSITION
- 15 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Jun 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Jun 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Jun 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Mar 2026 — NON-FINAL ACTION E-MAILED
- 18 Mar 2026 — NON-FINAL ACTION WRITTEN
- 13 Mar 2026 — ASSIGNED TO EXAMINER
- 25 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 25 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 25 Nov 2025 — NEW APPLICATION ENTERED